Pulmonary Medicine

Guest: Ryan Maves, MD

Guest: Susan Corbridge, PhD, APRN, ACNP-BC, FAANP, FCCP, FAAN

Although there have been several advances in vaccine technology and safety the past few years, the prevalence of vaccine hesitancy among patients is increasing. Since vaccine hesitancy heightens the burden of potentially life-threatening viruses like RSV and influenza, Dr. Ryan Maves speaks with Dr. Susan Corbridge about why patients might be reluctant to get vaccinated and how we can use the First 5 Minutes approach to provide individualized counseling on the importance of vaccines. Dr. Maves is a Professor of Medicine and Anesthesiology in the Sections of Infectious Diseases and Critical Care Medicine at the Wake Forest University School of Medicine, and Dr. Corbridge is a Professor Emerita at the University of Illinois at Chicago College of Nursing.

This episode is supported by an educational grant from Moderna.

Host: Angela Birdwell, DO, MA, FCCP

Guest: Antonio Anzueto, MD

Guest: Susan Corbridge, PhD, APRN, ACNP-BC, FAANP, FCCP, FAAN

Although the prevalence of chronic obstructive pulmonary disease (COPD) has decreased in adults aged 18 to 44, it remains elevated in certain patient groups, like women, adults over 65, smokers, and those living in rural areas. This prevalence emphasizes the importance of a patient-centered approach, which is why Dr. Angela Birdwell speaks with Drs. Antonio Anzueto and Susan Corbridge about how open conversations and the First 5 Minutes concept can help personalize the care of COPD patients and lead to better outcomes. Dr. Anzueto is a Professor of Medicine at the South Texas Veterans Health Care System and UT Health San Antonio, and Dr. Corbridge is the Chief Essentials Program Officer at the American Association of Colleges of Nursing and a Professor Emerita at the University of Illinois at Chicago College of Nursing.

This non-CME education is brought to you by CHEST, and this program is supported by Regeneron Pharmaceuticals, Inc. and Sanofi.

Guest: Surya Bhatt, MD

Guest: MeiLan Han, MD, MS

Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach.

Guest: Surya Bhatt, MD

Host: MeiLan Han, MD, MS

Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach.

Guest: Surya Bhatt, MD

Guest: MeiLan Han, MD, MS

Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach.

Guest: Surya Bhatt, MD

Guest: MeiLan Han, MD, MS

Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach.

Guest: Surya Bhatt, MD

Guest: MeiLan Han, MD, MS

Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory types, staying in formed about developing therapies, and adopting strategies that shift COPD management to a more personalized approach.

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA

Guest: Alissa Kanowitz, Founding Member Families Fighting Flu

Mrs. Alissa Kanowitz became a patient advocate after experiencing the absolute worst-case scenario: losing her four-year-old daughter Amanda to the flu. And now, she’s here with Dr. Mary Katherine Cheeley to share her and Amanda’s story as well as her experience working with the Families Fighting Flu organization. This is so we can all better understand the seriousness of influenza and work to stem the tide on this tragic disease.

Host: Martha Kingman, DNP, FNP-C

Guest: Susanne McDevitt, DNP, ACNP-BC

This program focuses on early symptom identification and timely diagnosis in patients with pulmonary hypertension (PH). Learn how appropriate risk stratification can facilitate the effective management of PH. Our experts also stress the importance of asking the right questions and offer strategies for achieving well-rounded communication with patients and their caregivers.

Guest: Eric D. Austin, MD, MSCI

Guest: Hilary M. DuBrock, MD

Guest: H. James Ford, MD

Guest: Gustavo A. Heresi, MD, MS

Guest: Gergely Meszaros, JD, MSc

Guest: Oksana A. Shlobin, MD

Guest: Ioana Preston, MD

Guest: Lucilla Piccari, MD, PhD

The 7th World Symposium Task Force on Pulmonary Hypertension focused on the standard of care, best practices, and emerging clinical data in the treatment of pulmonary hypertension (PH). For the first time, the 2024 Symposium started with patients’ perspectives, acknowledging the respect and importance that should be given to patients’ priorities. The translational aspects of modern pulmonary vascular research were highlighted, as were transplantation, bridging and support technologies, palliative care, management of pregnant women with PH, specificities of pediatric care, and the benefits of emerging multimodality imaging techniques and novel technologies. Tune in to get the details and improve care for your patients today!